Fig. 1
DLQI values (median ± DS) at baseline (t0) and after 6 months of treatment (t1) with vismodegib in patients with advanced BCCs categorized according to anatomical site (n; %)
Fig. 1 | Dermatology and Therapy
DLQI values (median ± DS) at baseline (t0) and after 6 months of treatment (t1) with vismodegib in patients with advanced BCCs categorized according to anatomical site (n; %)